Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: A unique case with morphologic, immunohistochemical, and genomic characterization

Medicine (United States)

Volumn 93, Issue 15, 2014, Pages

  Sirintrapun, Sahussapont J ^a   Geisinger, Kim R ^b   Cimic, Adela ^c   Snow, Anthony ^c   Hagenkord, Jill ^d   Monzon, Federico ^e   Legendre, Benjamin L ^f   Ghazalpour, Anatole ^h   Bender, Ryan P ^h   Gatalica, Zoran ^g,h  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c WAKE FOREST BAPTIST HEALTH   (United States)

^d 23andMe ^*  (United States)

^e Clinical Molecular Geneticist and Cytogeneticist Invitae Corportation   (United States)

^f Transgenomics   (United States)

^g CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h CARIS LIFE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MACROPHAGE ELASTASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; VASCULOTROPIN A;

AGED; ANGIOGENESIS; ARTICLE; CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GENE EXPRESSION; GENE SEQUENCE; HIGH GRADE ONCOCYTIC CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; KARYOTYPING; KIDNEY TUMOR; MALE; MALIGNANT TRANSFORMATION; ONCOCYTOMA; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION;

EID: 84916202818     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000081     Document Type: Article

References (26)

1. Monzon FA, Hagenkord JM, Lyons-Weiler MA, et al. Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors. Mod Pathol. 2008;21:599-608.
2. Hagenkord JM, Gatalica Z, Jonasch E, et al. Clinical genomics of renal epithelial tumors. Cancer Genet. 2011;204:285-297.
3. Presti JC Jr, Wilhelm M, Reuter V, et al. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney. J Urol. 2002;167:1464-1468.
4. Junker K, Romics I, Szendroi A, et al. Genetic profile of bone metastases in renal cell carcinoma. Eur Urol. 2004;45:320-324.
5. Klatte T, Kroeger N, Rampersaud EN, et al. Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma. Cancer. 2012;118:5777-5782.
6. Amin MB, Crotty TB, Tickoo SK, et al. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol. 1997;21:1-12.
7. Perez-Ordonez B, Hamed G, Campbell S, et al. Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol. 1997;21:871-883.
8. Morell-Quadreny L, Gregori-Romero MA, Carda-Batalla C, et al. Renal oncocytomas (typical and atypical variants): a pathologic, immunohistochemical, morphometric, and flow cytometric differential study of 14 cases with cytogenetic support Int J Surg Pathol. 1996;3:219-228.
9. Petersson F, Gatalica Z, Grossmann P, et al. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch. 2010;456:355-365.
10. Kuroda N, Tanaka A, Ohe C, et al. Review of renal oncocytosis (multiple oncocytic lesions) with focus on clinical and pathobiological aspects. Histol Histopathol. 2012;27:1407-1412.
11. Pimenta SP, Baldi BG, Nascimento EC, et al. Birt-Hogg-Dubé syndrome: metalloproteinase activity and response to doxycycline. Clinics (Sao Paulo). 2012;67:1501-1504.
12. Nishii T, Tanabe M, Tanaka R, et al. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome. Pathol Int. 2013;63:45-55.
13. Cash TP, Gruber JJ, Hartman TR, et al. Loss of the Birt-Hogg-Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFβ-mediated transcription. Oncogene. 2011;30:2534-2546.
14. Klomp JA, Petillo D, Niemi NM, et al. Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics. 2010;3:59.
15. Qin L, Han YP. Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis. Am J Pathol. 2010;177:1915-1928.
16. Bonacci G, Schopfer FJ, Batthyany CI, et al. Electrophilic fatty acids regulate matrix metalloproteinase activity and expression. J Biol Chem. 2011;286:16074-16081.
17. Kadono Y, Okada Y, Namiki M, et al. Transformation of epithelial Madin-Darby canine kidney cells with p60(v-src) induces expression of membrane-type 1 matrix metalloproteinase and invasiveness. Cancer Res. 1998;58:2240-2244.
18. Murillo MM, Castillo GD, Sánchez A, et al. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes. Oncogene. 2005;24:4580-4587.
19. Rodrigues S, Attoub S, Nguyen QD, et al. Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells. Oncogene. 2003;22:4488-4497.
20. Osunkoya AO, Cohen C, Lawson D, et al. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma. Hum Pathol. 2009;40:206-210.
21. Hu Y, Hartmann A, Stoehr C, et al. PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody. J Clin Pathol. 2012;65:254-256.
22. Geng H, Harvey CT, Pittsenbarger J, et al. HDAC4 protein regulates HIF1α protein lysine acetylation and cancer cell response to hypoxia. J Biol Chem. 2011;286:38095-38102.
23. Jiang BH, Agani F, Passaniti A, et al. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 1997;57:5328-5335.
24. Nam EH, Park SR, Kim PH. TGF-beta1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions. Exp Mol Med. 2010;42:606-613.
25. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883-892.
26. Longo DL. Tumor heterogeneity and personalized medicine. N Engl J Med. 2012;366:956-957.